Authors (time of publication) | Demographics | Comorbidities | Time interval with COVID-19 diagnosis | Method of COVID-19 diagnosis | Severity of COVID-19* | Ocular manifestation | Positive coagulopathy studies ** |
---|---|---|---|---|---|---|---|
Insausti et al. [17] (July 2020) | 40 y/o male | Negative | 6 weeks before | ELISA | Mild | CRVO in left eye | d-Dimer (672 μg/L), Fibrinogen (451 mg/dL) |
Sheth et al. [18] (October 2020) | 52 y/o male | Negative | 10 days before | PCR | Moderate | Inferior HCRVO with superonasal BRVO in left eye | Unremarkable |
Gaba et al. [19] (October 2020) | 40 y/o male | Hypertension, morbid obesity, deep vein thrombosis | 3 days before | PCR, HRCT | Severe | Bilateral CRVO | d-Dimer (> 20000 µg/L) |
Invernizzi et al. [20] (November 2020) | 54 y/o female | Negative | 5 days before | Not mentioned | Mild | CRVO in right eye | PT (13.8 s) INR (1.27) Fibrinogen (682 mg/dL) |
Walinjkar et al. [21] (November 2020) | 17 y/o female | Polycystic ovaries | 23 days before | HRCT, serology (IgG) | Mild | CRVO in right eye | Unremarkable |
Yahalomi et al. [22] (December 2020) | 33 y/o male | Negative | 5 to 2 weeks before | Serology (IgG) | Mild | CRVO in left eye | Slightly abnormal fibrinogen and d-Dimer |
Monferrer et al. [23] (December 2020) | 59 y/o female | DM | 18 days after ocular manifestations | PCR | Mild | Bilateral CRVO | Thrombocytopenia (126 × 109/L) |
Lorca et al. [24] (December 2020 | 30 y/o female | DM (maturity onset) | 1 month after discharge | Not mentioned | Moderate | Bilateral CRVO | Substantial increases value of d-dimer, ferritin, fibrinogen, and platelets |
Duff et al. [16] (February 2021) | 74 y/o female | Hyperlipidemia | Concurrent | Not mentioned | Mild | Infratemporal BRVO in left eye; CME occurred 3 months later | Unremarkable |
Finn et al. [15] (March 2021) | 32 y/o male | Negative | 2 months before | PCR and ELISA | Mild | inferior HCRVO in right eye | Unremarkable |
Raval et al. [25] (April 2021) | 39 y/o male | Negative | 7 days before | PCR | Mild | CRVO in right eye | Unremarkable |
Venkatesh et al. [26] (May 2021) | 56 y/o female | DM | Asymptomatic | Serology (IgG) | Asymptomatic | CRVO in left eye | d-Dimer (707 μg/L), PT (14.8 s) INR (1.18) |
Al-Abri et al. [27] (July 2021) | 33 y/o male | Negative | 6 month prior to the presentation *** | Not mentioned | Mild | CRVO in left eye | Unremarkable |
Staropoli et al. [9] (April 2022) | 15 y/o male | Homozygous for MTHFR | Concurrent | PCR | Asymptomatic | CRVO in left eye | Homozygous MTHFR Normal homocysteine levels |
Modjtahedi et al. [28] (April 2022) | A cohort of 16 patients (among 432,515 patients with COVID-19) | Not determined | From 2 weeks before to 26 weeks after diagnosis | PCR | N/A | Not determined on the basis of every patients | N/A |